Atlas Trials

Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)

Clinical trial NCT01308905 · UNKNOWN

Trial details

NCT number
NCT01308905
Sponsor
Barbara Ann Karmanos Cancer Institute
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Neuroblastoma
Start date
2011-02-01
Primary completion
2018-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.